AMY KNICKERBOCKER: Open Payments
NPI 1194209031 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 33 payments from 15 companies in 2025. Trend: 2023 $113 · 2024 $338 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $191 |
| IBSA Pharma Inc. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| ABBVIE INC. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Medtronic, Inc. | 2 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $23 |
| Amgen Inc. | 1 | $22 |
Products named: Ozempic, Tirosint, JARDIANCE, SYNTHROID, Wegovy, Kerendia, MINIMED 780G, TZIELD.
Industry payments across PA — which companies pay providers there.
